Colorectal Cancer Screening Guidelines
Colorectal cancer (CRC) remains the 3rd most commonly diagnosed cancer among men and women and the second overall leading cause of cancer-related death. Despite declines in both incidence and mortality over the past 2 decades, ~ 142,480 new cases and ~50,830 deaths are projected for 2013. This CME activity encompasses the most recent guidelines on screening initiation, screening intervals and screening follow-up.
- Describe the epidemiology of colorectal cancer (CRC).
- Articulate the rationale for early screening of CRC.
- List screening options and provide supporting evidence for these options.
- Summarize screening recommendations and interval screenings.
Paul C. Schroy III, M.D., M.P.H.
Professor of Medicine, Boston University School of Medicine Director of Clinical Research, GI Section, Boston Medical Center
Course Fees: Free
Format: Text and Graphics
CME Credit: 1 AMA PRA Category 1 Credit™, risk management study
The Massachusetts Medical Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society and the Massachusetts Department of Public Health.
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
A score of 70% or higher is required to receive AMA PRA Category 1 Credit™.
Windows, XP, Vista, 7, 8
Mac OSX 10.6 higher
Most modern browsers including:
Flash player is required for some Online CME courses.
iOS devices beginning with OS version 5 or higher (includes, iPhone, ipad and iTouch devices)
Android devices including tablets and phones.
Windows RT and tablets on Windows 8 are also supported.